Kale Mayura A, Faisal Mohammed
Government College of Pharmacy, Masur Road, Saidapur, Karad, 415124, Maharashtra, India.
Government College of Pharmacy, Osmanpura, Aurangabad, 431005, Maharashtra, India.
Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.
It is a known fact that Alzheimer's disease causes degeneration of the central nervous system, which progresses and causes memory loss as well as loss of cognition. For many years, extensive research has been undertaken to find out newer possibilities to fight this disease at a molecular level along with many long-standing and expensive clinical trials. Many scientific research programs have either been discarded or unsuccessful. However, the research has not stopped and in the process, many heterocyclic scaffolds have been tried to build up novel drug molecules to combat this disease. A literature survey reveals that many heterocycles have been explored and were found to be very useful in treating many neurodegenerative disorders, including Alzheimer's disease, Parkinsonism and a few more. This review explains the journey and highlights the various strategies to develop new anti-Alzheimer drug candidates. It is a concise and rigorous literature excerpt involving research findings on heterocyclic scaffolds for treating this disease.
众所周知,阿尔茨海默病会导致中枢神经系统退化,这种退化会不断进展,导致记忆力丧失以及认知能力丧失。多年来,人们进行了广泛的研究,以寻找在分子水平对抗这种疾病的新可能性,同时还开展了许多长期且昂贵的临床试验。许多科研项目要么被放弃,要么未取得成功。然而,研究并未停止,在此过程中,人们尝试了许多杂环骨架来构建新型药物分子以对抗这种疾病。一项文献调查显示,许多杂环已被探索,并且发现它们在治疗包括阿尔茨海默病、帕金森症等多种神经退行性疾病方面非常有用。这篇综述解释了这一历程,并强调了开发新型抗阿尔茨海默病候选药物的各种策略。它是一篇简洁而严谨的文献摘录,涉及用于治疗这种疾病的杂环骨架的研究成果。